O2015_011 and O2015_012; 13 June 2017

Main hearing at the Swiss Federal Patent Court Case IDs: O2015_011 and O2015_012 Date: 13 June 2017 Time: 9:30am Plaintiff: Actavis Switzerland AG Defendant: AstraZeneca AB Subject: Nullity of EP 1 250 138 B2 and EP 2 266 573 B1 Market: Faslodex, Fulvestrant